Welcome to the CBCF Tumor Bank

Historical Stories

Tumor banks have played pivotal roles in the development of diagnostic tools and therapeutic reagents, including Her-2/neu (amplified in breast cancers), prostate specific antigen (PSA test), CA125 antigen test for ovarian cancers, Herceptin (antibody therapy targeted to Her-2/neu in treatment of breast cancers) and Rituximab (monoclonal antibody to CD20) for treatment of B cell malignancies.

Find out more about our history

Did you know?

An estimated 153,100 new cases of cancer will occur in Canada in 2006.

* On average, 1,354 Canadians will die of cancer every week.
- Canadian Cancer Statistics, 2006

Based on current incidence rates, 38% of Canadian women will develop cancer during their lifetimes. Among men, 44% will develop cancer during their lifetimes.
- Canadian Cancer Statistics, 2006

How do I donate? There are many ways...

Donating tumor tissue specimens to the CBCF Tumor Bank

A promising area of cancer research is the identification and characterization of biomarkers that can predict the response of cancer...

Click here to read more
Find out ways to donate

Upcoming Events

Welcome to the new Canadian Breast Cancer Foundation Tumor Bank homepage! The CBCF TB provides a comprehensive collection of cancer specimens with related clinical information that will enable researchers to address unanswered questions...

Click here to read more

The Canadian Breast Cancer Foundation - Prairies/NWT Chapter currently funds the CBCF Tumor Bank (CBCF TB) and is created by a merger of components of two existing tumor-banking initiatives, the CLS Repository in Calgary and the tumor bank of the PolyomX Program in Edmonton.

Click here to read more